- Home
- GNW vs CPRX Comparison
GNW vs CPRX Comparison
Compare GNW & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNW
- CPRX
- Stock Information
- Founded
- GNW 1871
- CPRX 2002
- Country
- GNW United States
- CPRX United States
- Employees
- GNW N/A
- CPRX N/A
- Industry
- GNW Life Insurance
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- GNW Finance
- CPRX Health Care
- Exchange
- GNW Nasdaq
- CPRX Nasdaq
- Market Cap
- GNW 2.9B
- CPRX 2.6B
- IPO Year
- GNW 2004
- CPRX 2006
- Fundamental
- Price
- GNW $7.37
- CPRX $24.46
- Analyst Decision
- GNW Hold
- CPRX Strong Buy
- Analyst Count
- GNW 1
- CPRX 7
- Target Price
- GNW $7.00
- CPRX $32.29
- AVG Volume (30 Days)
- GNW 5.3M
- CPRX 1.5M
- Earning Date
- GNW 04-30-2025
- CPRX 05-07-2025
- Dividend Yield
- GNW N/A
- CPRX N/A
- EPS Growth
- GNW 323.28
- CPRX 107.94
- EPS
- GNW 0.68
- CPRX 1.31
- Revenue
- GNW $7,295,000,000.00
- CPRX $491,734,000.00
- Revenue This Year
- GNW N/A
- CPRX $15.17
- Revenue Next Year
- GNW N/A
- CPRX $9.61
- P/E Ratio
- GNW $10.88
- CPRX $18.67
- Revenue Growth
- GNW N/A
- CPRX 23.49
- 52 Week Low
- GNW $5.67
- CPRX $14.47
- 52 Week High
- GNW $7.90
- CPRX $26.16
- Technical
- Relative Strength Index (RSI)
- GNW 63.89
- CPRX 59.36
- Support Level
- GNW $6.96
- CPRX $23.52
- Resistance Level
- GNW $7.28
- CPRX $26.16
- Average True Range (ATR)
- GNW 0.20
- CPRX 0.88
- MACD
- GNW 0.06
- CPRX 0.12
- Stochastic Oscillator
- GNW 97.92
- CPRX 68.05
About GNW Genworth Financial Inc
Genworth Financial is a diversified insurance holding company that provides various mortgage and life insurance products. The company has three main operating business segments: Enact, Life and Annuities segment and Long-Term Care Insurance. The company's product portfolio includes various financial products such as traditional life insurance, mortgage insurance, fixed annuities, and variable annuities. most of the revenue is generated by the Long-Term Care Insurance segment. The company earns most of its revenue in the United States.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.